Time-Dependent Resistance to Erythropoiesis-Stimulating Agent and Mortality in Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study

By  

Nephron Clin Pract, Vol. 122, Iss. 1-2, 2013-03 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients

By Biolo Gianni   Guarnieri Gianfranco   Barazzoni Rocco   Panzetta Giovanni  

Clinical and Experimental Medicine, Vol. 11, Iss. 3, 2011-09 ,pp. : 181-187

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Synthetic Vitamin E-Bonded Membrane on Responsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Pilot Study

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-03 ,pp. : c82-c89

Karger

Access to resources Recommend Favorite

Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia – examination of practice in Germany

By Steinmetz T.   Totzke U.   Söling U.   Groschek M.   Mittermüller J.   Schweigert M.   Tesch H.   Nawka S.   Schmitz S.   Tsamaloukas A.  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2751-2756

Informa Healthcare

Access to resources Recommend Favorite

Cost Should Be the Principal Determinant of Choice of Erythropoiesis-Stimulating Agent in Chronic Haemodialysis Patients

By  

Nephron Clin Pract, Vol. 107, Iss. 1, 2007-07 ,pp. : c14-c19

Karger

Access to resources Recommend Favorite